NCT07237009

Effects of Personalized Digital Reminiscence Therapy on Patients With Neurocognitive Disorders

Effects of Personalized Reminiscence Sessions Delivered by a Digital Conversational Agent to Patients With Neurocognitive Disorders

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 80 (estimated)
• Sponsor: KompanionCare SAS · Industry
• Sex: All
• Age: 60 Years
• Healthy volunteers: Not accepted

Summary

This study aims to observe the effects of daily personalized digital reminiscence sessions, conducted with the help of a digital conversational agent, and to determine whether these sessions lead to improvements in symptoms such as apathy and depression. The researchers therefore seek to observe whether this daily use can improve certain aspects of well-being, such as motivation, mood, sleep quality, quality of life, and engagement with the tool. The study also aims to assess whether simple reminders delivered via the application are sufficient to encourage regular use without external assistance. Participants will: * Use the reminiscence app for 25 days for 10-15 minutes. * Have a primary caregiver help personalize the app by sharing family memories, other relatives may optionally contribute in a private group. * Complete brief questionnaires at the start and during follow-up routine visits (for example, apathy and depression scales, sleep, and quality of life).

Conditions

• Neurocognitive Disorders, Mild
• Cognitive Impairment, Mild
• Depression Mild
• Apathy
• Apathy in Dementia

Timeline

• Start date: 2025-10-14
• Primary completion: 2026-12-01
• Completion: 2026-12-01
• First posted: 2025-11-19
• Last updated: 2026-03-09

Locations

5 sites across 1 country: France